West Pharmaceutical Services (WST) Revenue — Quarter Ended Dec 31, 2023
Revenue declined compared to the immediately preceding quarter but rose compared to the same quarter one year earlier. The sequential drop followed a mixed trend across the trailing four quarters.
Key takeaway
Quarter ended Dec 31, 2023 · FY2023 Q4
Revenue declined compared to the immediately preceding quarter but rose compared to the same quarter one year earlier. The sequential drop followed a mixed trend across the trailing four quarters.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$732M
Revenue reported for this quarter.
Quarter-over-quarter
-2.1%
Change from the immediately preceding quarter.
Year-over-year
+3.3%
Change from the comparable year-ago quarter.
Trailing four quarters
$2.9B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Mar 31, 2023 | $716.6M | -0.5% |
| Jun 30, 2023 | $753.8M | -2.3% |
| Sep 30, 2023 | $747.4M | +8.8% |
| Dec 31, 2023 | $732M | +3.3% |
Revenue performance
The reported revenue for the quarter decreased from the prior quarter, while it increased from the year-ago period.
Quarterly comparison
Compared with the immediately preceding quarter, revenue was lower, but compared with the same quarter one year earlier, revenue was higher.
What to watch
The sequential decline may warrant attention given the uneven quarterly revenue pattern over the trailing year.